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Introduction
An increased thickness of the capillary basement 
membrane (BM) has been found in a variety of tis-
sues during aging and as a consequence of systemic 
diseases, such as hypertension and diabetes.1 BM 
plays an important role in the regulation of capil-
lary permeability and the thickening of these struc-
tures may alter the exchange of substances between 
the internal and external environment of the capil-
laries. Normal human aging is associated with a 
gradual decrease in cerebral blood flow due to 
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Normal human aging and diabetes are associated with a gradual decrease of cerebral flow in the brain with changes 
in vascular architecture. Thickening of the capillary basement membrane and microvascular fibrosis are evident in the 
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role of vascular endothelial growth factor (VEGF) and pro-inflammatory cytokines in diabetic retina.
Transmission electron microscopy (TEM) was performed on 46 enucleated human eyes with particular attention 
to alterations of the retinal capillary wall and Müller glial cells. Inflammatory cytokines expression in the retina was 
investigated by immunohistochemistry.
Our electron microscopy findings demonstrated that thickening of the BM begins primarily at the level of the glial side 
of the retina during aging and diabetes. The Müller cells showed numerous cytoplasmic endosomes and highly electron-
dense lysosomes which surrounded the retinal capillaries. Our study is the first to present morphological evidence that 
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modifications of vascular architecture, vessel walls, 
regulation of blood flow, or vascular plasticity and 
in the concentration of neurotransmitters due to a 
reduction of the metabolism in general.2 These 
morphological abnormalities may reduce the blood 
supply to the brain parenchyma. The retina is an 
extension of the central nervous system (CNS) and 
extensive evidence suggests that the retinal vessels 
present age-related abnormalities similar to those 
found in the brain, such as thickening of the capil-
lary BM and an increase in the incidence of microa-
neurysms, hemorrhages, and exudates.3 Diabetic 
disease may also cause retinal damage that results 
in severe loss of vision in adults between the second 
and seventh decades of life in industrialized coun-
tries.4 Despite the advances in medical care, thera-
peutic approaches are still inadequate, awing to the 
complex etiology of this disease. The risk of devel-
oping diabetic retinopathy increases with age and 
retinopathic changes are appreciable in 98% of 
patients with type 1 diabetes and 78% with type 2 
diabetes. In addition, 33% of patients with type 1 
diabetes and 17% of those with type 2 diabetes will 
also develop proliferative diabetic retinopathy 
(PDR): this occurs after neovascularization of the 
retina or iris, followed by fibrocontractive pro-
cesses that cause retinal detachment and blindness. 
Some of the most visible ophthalmoscopic signs in 
the diabetic retina are vascular lesions (microaneu-
rysms, capillary degeneration, vessel growth, 
increased vascular permeability, hemorrhages) and 
neuronal cell death, alterations in glial cell structure 
and function, and inflammation.5 Thickening of 
capillary BM is well documented both in human 
diabetics as well as in animal models of experimen-
tal diabetes.6,7 Other authors have previously estab-
lished that diabetes-induced peroxynitrite formation 
and inflammation are the major molecular mecha-
nisms responsible for retinal endothelial dysfunc-
tion and vascular cell death.8,9 This diabetic 
retinopathy involves a chronic, low-grade inflam-
matory component.10 Elevated cytokines activate 
microglia, thereby stimulating a cycle of inflamma-
tion that recruits leukocytes, causes vascular break-
down, and directly induces cell death through the 
release of cytotoxic substances.11
Some studies suggest that diabetic retinopathy 
has many characteristics in common with low-
grade inflammatory diseases. The levels of pro-
inflammatory cytokines are increased in the diabetic 
retina and vitreous body, the retinal capillaries 
become non-perfused and ischemic with an 
increased number of platelet-fibrin thrombi.12 
Different molecular and cellular alterations typical 
of inflammatory processes have been observed in 
the retinas of diabetic animals and patients. 
Different evidence supports the idea according to 
which the DR is a manifestation of a chronic low-
level inflammation in which different effectors, e.g. 
the cytokines and the leukocytes, are responsible 
for retinal damage.13 Diabetic retinopathy presents 
many similarities to chronic inflammatory diseases: 
increase in vascular permeability, edema, infiltra-
tion of inflammatory cells, tissue destruction, neo-
vascularization, and retinal expression of 
inflammatory cytokines. Recent publications pre-
sent strong evidence of an important inflammatory 
involvement even in the early stages of DR.14 It has 
been demonstrated that, both in animals and patients 
with diabetes, the leukocytes, including monocytes/
macrophages (microglia), neutrophils, and a certain 
number of lymphocytes, show adhesion to the reti-
nal vascular endothelium. This occurs simultane-
ously with impairment damage of the blood–retina 
barrier, capillary occlusion, and death of the 
endothelial cells. The expression of adhesion mol-
ecules, particularly of ICAM-1 (intracellular adhe-
sion molecule-1) and VCAM-1 (vascular cell 
adhesion molecule-1), appears increased in the dia-
betic retina and is connected with an increased leu-
kocyte adhesion and leukostasis.15 Inflammation 
contributes to the development and the progression 
of retinopathy, as it is demonstrated by the fact that 
intravenous administration of glucocorticoids and 
anti-VEGF drugs may improve the clinical condi-
tions.16 Growth factors, neurotrophic factors, and 
hormones may alter the levels of certain molecules 
that have been found in diabetic subjects: insulin, 
IGF-1 (insulin-like growth factor-1), aldosterone, 
adrenomedullin, GH, endothelin, VEGF, PEDF, 
FGF (fibroblast growth factor), and TGF-β (trans-
forming growth factor-β). These elements are all 
responsible for the structural changes of retinal vas-
cularization (angiogenesis, ischemia, and increased 
vessel permeability) and for the progression of 
DR.13 Neurotrophic factors such as insulin, PEDF, 
CNTF (ciliary neurotrophic factor), NGF (nerve 
growth factor), GDNF (glial cell line-derived neu-
rotrophic factor), and BDNF (brain-derived growth 
factor), all of which appear altered in the diabetic 
subject, are also responsible for retinal neuronal 
damage.13
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Intraocular levels of inflammatory factors, 
which are expressed by alterations of migrating 
leukocytes, glial cells, and vascular endothelial 
cells, were significantly correlated with the sever-
ity of DR, suggesting they play an important role in 
the occurrence of macular edema. The structure of 
retinal vessels has been well described by many 
authors.17,18 The continuous lining of endothelial 
cells lies upon a homogeneous basal lamina, 
enclosing muscle cells or pericytes, which is par-
ticularly prominent where it separates the vessel 
from the nervous tissue. The outer basement mem-
brane consists of two layers: the basal lamina of 
the outer vascular cells-mesodermal basement 
lamina (MBL) and that of the Müller cells-ectoder-
mal basement lamina (EBL). Thickening of the 
perivascular basement membrane has been shown 
to develop with advancing age19 and appears to be 
related to hydrostatic pressure, as well as to vari-
ous pathological conditions, such as oxygen-poi-
soning, hypertension, myxoedema, polymyositis, 
and lupus erythematosus.20 The various pathologi-
cal manifestations of retinopathy, such as microa-
neurysms, zones of capillary non-perfusion, 
pericyte cell death, and thickening of vascular BM 
have been consistently reported.6,7 Of all these 
changes, BM thickening has received the most 
attention, being the major and earliest morphologi-
cal characteristic of diabetic microangiopathy, not 
only in the retina, but also in the kidneys,21 mus-
cle,22 and skin23 of humans and diabetic animals. 
Several studies have sought to measure BM thick-
ening of the retinal capillaries and have quantita-
tively confirmed BM thickening during diabetes.24 
These studies found significant differences in the 
BM thickness of capillaries from the different reti-
nal layers in normal rats: capillaries in the nerve 
fiber layer (NFL) showed significantly thicker BM 
than capillaries located within either the inner 
plexiform layer (IPL) or the outer plexiform layer 
(OPL). Furthermore, a study on diabetic dogs 
showed that retinal capillaries located in an arterial 
environment had significantly thicker BM when 
compared to those of capillaries found in a venous 
environment.25 Müller cells, the principal retinal 
glial cells, play an important causal role in the 
development of diabetic retinopathy. Müller cells 
may respond to retinal injury, insults, or changes 
by an altered expression of cytoskeletal proteins 
and enzymes, cellular hypertrophy, proliferation, 
and migration in the vitreous body.26 Studies of 
Müller cells in animal models and tissue culture 
revealed the capacity of this cell type to generate 
tractional forces and cause retinal detachment.27 
Thickening of the capillary basement membrane, 
appearance of acellular capillary remnants, ultras-
tructural signs of pericyte degradation, and vascu-
lar tortuosity have also been observed in the aged 
rat retina. Pericytes, the mural cells on capillaries, 
are thought to play a role in the vessel stabilization 
(regulating endothelial cell proliferation and pre-
venting capillary withdrawal)28 and in the regula-
tion of capillary blood flow.29 Alterations in these 
cells with age and diabetes may contribute to the 
development of morphological and physiological 
abnormalities of the microvasculature. Close con-
tact between pericytes and endothelial cells is nec-
essary for maintaining vascular stability.30 In the 
rat retina, during aging and diabetes, ultrastructural 
observations have shown that the decrease of peri-
cytes and the alter pericyte-endothelial relationship 
may cause vessel instability.31
The aim of this study was to identify changes of 
the retinal capillaries in humans during aging and 
diabetes. Immunohistochemical technique was 
employed to investigate the expression of growth 
factors and pro-inflammatory cytokines (ICAM-1, 
VEGF, tumor necrosis factor [TNF]-α, interleu-
kin-1 [IL-1β], and interleukin-6 [IL-6]) involved in 
the pathogenesis of DR. In the present study, using 
TEM, retinal alterations were investigated, playing 
particular attention to alterations of the retinal cap-
illary wall (BM and pericytes) and Müller glial 
cells in type 2 diabetes as compared to age-matched 
healthy controls.
Materials and methods
Forty-six enucleated human eyes (age range, 6–83 
years) were selected for these electron microscopic 
studies. Samples of retina were harvested from the 
left eye during autopsies. Postmortem phenomena 
may produce early morphologic modifications of 
the eye structure, therefore our samples were har-
vested as early as possible after death in Hungarian 
hospitals (within 24 h). All experiments were con-
ducted in accordance with the Declaration of 
Helsinki (1964) and in conformity with the ARVO 
Statement for use of human samples in Ophthalmic 
and Vision Research. The Ethical Committees of 
the hospitals involved gave their approval and the 
relatives of the dead humans gave their written 
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informed consent. Four eyes, aged 6, 62, 81, and 
83 years, were used only for qualitative analysis of 
age-related changes. Twenty-one of the eyes were 
harvested from patients suffering from type 2 dia-
betes (age range, 42–87 years; mean age, 70.9 
years; 20 women, 11 men) and another 21 were 
used as age-matched controls for both qualitative 
and quantitative morphometric studies. These sam-
ples were shipped to our laboratory in 0.1 M Tris-
buffered saline with protease inhibitors (0.025 M 
ethylenediaminetetraacetic acid [EDTA], 0.001 M 
benzamidine hydrochloride, 0.001 M phenyl-
methysulfonyl fluoride [PMSF], 0.01 M 
N-ethylmaleimide [NEM]) on wet ice. All tissues 
used in the current study were from patients with 
known type 2 diabetes or age-matched controls 
(individuals with no prior history of disease). 
Retinas were removed from whole eyes and poste-
rior eye cups and were immersed overnight in 
2–5% glutaraldehyde (in 100 mmol/L phosphate 
buffer pH 7.4). The retina was postfixed in 1% 
buffered osmium tetroxide and dehydrated using 
graded ethanol solutions. Ultrathin sections (0.5 
µm) of selected areas were then prepared and 
stained with uranyl acetate and lead citrate for 
transmission electron microscope (H7650TEM, 
Hitachi, Tokyo, Japan). Capillaries were then pho-
tographed at magnifications in the range of 8.000–
24.000, the images transferred to an image analysis 
system and calibrated according to magnification. 
The retinal layer in which each capillary was 
located, the NFL, the IPL, and the OPL were also 
recorded. The method used to measure the two-
dimensional (2D) thickness of the retinal capillary 
BM has been previously described in detail by Stitt 
et al.18 However, a brief description will also be 
given below. A 2D grid of lines 15 mm apart was 
superimposed over each capillary profile on the 
image analyzer and, at the points where a grid line 
intercepted the BM, the shortest distance across the 
BM was measured. This method resulted in approx-
imately 25–30 measurements of BM thickness per 
capillary and these values were then used to deter-
mine the mean BM thickness for each individual 
capillary sampled. The results were then analyzed 
by a two-way analysis of variance (ANOVA) as 
well as by a two tailed Student’s t-test.
Immunohistochemical analysis
Control morphological sections were stained with 
hematoxylin-eosin stain (not shown). The following 
molecules were investigated: VEGF, IL-1β, IL-6, 
TNF-α, and ICAM-1. Small fragments of retina 
were washed in PBS, fixed in 10% formalin, and 
embedded in paraffin according to a standard proce-
dure. The method employed for immunohistochem-
ical tests was ABC/HRP technique (avidin 
complexed with biotinylated peroxidase). Serial 
3-µm thick sections were cut using a rotative 
microtome, mounted on gelatin-coated slides, and 
processed for immunohistochemistry. These sec-
tions were deparaffinized in xylene and dehydrated. 
They were immersed in citrate buffer (pH 6) and 
subjected to microwave irradiation twice for 5 min 
(750 Watts). Subsequently, all sections were treated 
for 30 min with 0.3% hydrogen peroxide in metha-
nol to quench endogenous peroxidase activity. To 
block non-specific binding, the slides were incu-
bated in 6% normal goat serum in PBS for 30 min at 
room temperature. The slides were incubated over-
night at 4°C with primary mouse monoclonal anti-
bodies (dilution: 1/100) against human VEGF 
(Santa Cruz, sc-53462), against human TNF-α 
(Santa Cruz, sc-52746), against human ICAM-1 
(Santa Cruz, sc-107), and with primary rabbit poly-
clonal antibody against human IL-1β (Santa Cruz, 
sc-7884) and against human IL-6 (Santa Cruz, 
sc-7920). Optimal antisera dilutions and incubation 
times were assessed in a series of preliminary exper-
iments. After exposure to the primary antibodies, 
slides were rinsed twice in phosphate buffer and 
incubated for 1 h at room temperature with the 
appropriate secondary biotinylated goat anti-mouse 
or anti-rabbit IgG (Vector Laboratories, Burlingame, 
CA, USA; BA9200 and BA1000) and with peroxi-
dase-conjugated avidin (Vector Laboratories, 
Burlingame, CA, USA; Vectastain Elite ABC Kit 
Standard* PK 6-100) for 30 min. After a further 
wash with phosphate buffer, slides were treated with 
0.05% 3,3-diaminobenzidine (DAB) and 0.1% 
H2O2. Finally, sections were counterstained with 
Mayer’s hematoxylin and observed using a light 
microscope. Negative control experiments were 
done: (1) by omitting the primary antibody; (2) by 
substituting the primary antibody with an equivalent 
amount of non-specific immunoglobulins; and (3) 
by pre-incubating the primary antibody with the 
specific blocking peptide (antigen/antibody=5 
according to supplier’s instructions). The staining 
assessment was made by two experienced observers 
in light microscopy. We assessed the immunoreac-
tivity for VEGF, IL-6, IL-1β, TNF-α, and ICAM-1 
in the retina. The intensity of the immune reaction 
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was assessed microdensitometrically using an IAS 
2000 image analyzer (Delta Sistemi, Rome, Italy) 
connected via a TV camera to the microscope. The 
system was calibrated taking the background 
obtained in sections exposed to non-immune serum 
as zero. Ten 100 µm2 areas were delineated in each 
section by measuring the diaphragm.
Results
Transmission electron microscopy
Transmission electron microscopy (TEM) exami-
nation of the retinas from diabetic patients showed 
increased thickening of the capillary BM when 
compared with those of the control patients. The 
most relevant thickening of the BM was observed 
in diabetic capillaries, but it was similar to that due 
to aging. TEM examination on the cross-section 
through normal human retinal capillaries showed 
that they comprise inner continuous layers of 
endothelial cells surrounded by discontinuous pro-
cesses of intramural pericytes. Retinal capillaries 
are formed by endothelial cells, pericytes, and BM. 
The BM consisted of: an inner subendothelial base-
ment membrane (IBM) interposed between 
endothelial cells and pericytes; an external base-
ment membrane (EBM) placed between pericytes 
and Müller glial cells (Figure 1a). In some areas 
the external basement membrane (EBM) showed 
double contours corresponding to endothelial-peri-
cyte contact sites (Figure 1b). In retinal capillaries 
from control patients, numerous mitochondria and 
cytoplasmic organelles are detected both in 
endothelial cells and pericytes (Figure 1c), while in 
other areas in the EBM numerous vacuoles were 
observed (Figure 1d). We identified the presence of 
another contact site between an endothelial cell 
and pericyte together with a pinocytotic vesicle 
indicating a direct cytoplasmic communication 
between these cells (Figure 1c). In addition, the 
perivascular connective tissue space consisted of a 
basement membrane-like pericytic matrix (PMC) 
and numerous collagen fibrils. Normal adult human 
retinal capillaries (age range, 62–83 years) showed 
Figure 1. The retinal capillary wall of a 6-year-old boy. (a) Retinal capillaries (cap) are formed by two distinct layers: the inner 
layer (ibm) placed between the endothelial cells (en) and the pericytes (pc), and the external layer (ebm) interposed between the 
pericytes and the Müller glial cells (gl). Magnification 8000×. (b) Endothelial cells-pericyte contact sites (arrows). Magnification 
24,000×. (c) Another contact site between pericyte (pc) and endothelial cell (en) with a pinocytotic vesicle indicating direct 
cytoplasmic communication between these cells. Both endothelial cells and pericytes have numerous mitochondria (m) and other 
cytoplasmic organelles. Magnification 24,000×. (d) In some places, we can see vacuoles in the external basement membrane (ebm). 
Magnification 24,000×.
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that the endothelial cell structure is well preserved 
while pericytes form an incomplete layer. A thin 
IBM between endothelial cells and pericytes may 
be seen all over. There was marked evidence of 
significant thickening of the EBM (Figure 2a). 
Endothelial cells contained numerous endosomes 
and cytoplasmic organelles while the thin cyto-
plasm of pericytes showed a poor content of orga-
nelles (Figure 2c). The endothelial cell-pericyte 
contact site may be observed (Figure 2b). 
Differently, the EBM presented very evident thick-
ening and contained some rudimentary processes 
of pericytes (Figure 2a, b). In addition, the EBM 
showed some vacuoles or “empty” areas and elec-
tro-dense granules (Figure 2c). Furthermore, we 
detected some irregularities of the border between 
the EBM and Müller cells. TEM examination of 
retinas removed from type 2 diabetic patients 
showed increased thickening of the capillary BM 
when compared with those of the control patients. 
An extreme thickening of the BM was observed in 
diabetic capillaries located in the NFL close to the 
inner limiting membrane. In diabetic patients, the 
microvascular extracellular matrix (ECM) sub-
components, including the BM layer, are variously 
altered with loss of pericytes. The BM was vacuo-
lated and contained osmophilic and cellular debris 
(probably resulting from degenerative pericytes) 
and occasionally reticulin fibers. The changes in 
the walls of capillaries were of a different nature 
and the greatly thickened laminated BM contained, 
in addition, blood elements such as lipid, platelets, 
and red cells. The pericytes within the wall were 
not usually involved in the thickening seen in the 
Figure 2. The retinal capillary wall of an 81-year-old man. (a) The structure of endothelial cells (en) is well preserved. Pericytes 
(PC) form a discontinuous layer around the circumference of retinal capillary (cap) and a thin internal basement membrane can 
be seen between endothelial cells and pericytes. Significant thickening of the external basement membrane (ebm). Magnification 
8000×. (b) Endothelial cell-pericyte contact site (arrow) can be identified in a photo at higher magnification. External basement 
membrane (ebm) contains some rudimentary processes of pericytes. Magnification 24,000×. (c) Endothelial cells (en) show 
numerous endosomes and cytoplasmatic organelles, while the cytoplasm of pericytes (pc) presents few organelles. The external 
basement membrane (ebm) contains some vacuoles (black arrowheads). The contact site between endothelial cell and pericyte can 
be observed (arrow). Magnification 24,000×. (d) The border between external basement membrane (ebm) and Müller cells (gl) is 
clearly visible. The external basement membrane (ebm) contains some vacuoles (black arrowheads). Magnification 24,000×.
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membrane around the vessel. The endothelial cells 
and pericytes had a normal appearance and there 
was a thin IBM, but the EBM containing some 
electro-dense granules and vacuoles was signifi-
cantly thickened (Figure 3). The external mem-
brane formed root-like extensions deeply inserted 
between Müller cells (Figure 4). An irregular bor-
der zone between the BM and Müller cells may 
also be observed. The data concerning the thicken-
ing of capillary basement membrane during aging 
and diabetes are provided in detail in Tables 1 and 
2. Thickening of the BM of retinal capillaries dur-
ing aging are shown in Table 1 with P value = 
0.0004; thickening of the BM of retinal capillaries 
during diabetes are shown in Table 2 with P value = 
0.0001.
Immunohistochemistry
Sections of diabetic retina exposed to the primary/
secondary antibodies, developed a dark-brown 
(intense), yellow-brown (slight), or no appreciable 
immunostaining. In diabetic retina, VEGF immu-
noreactivity was observed in several types of cells 
(Figure 5a, b), including retinal pigment epithelial 
cells, retinal microvascular endothelial cells, reti-
nal pericytes, and Müller cells in cells infiltrating 
the subretinal space, particularly those in highly 
vascularized regions (Figure 5c). VEGF immuno-
reactivity was observed in the blood vessels situ-
ated in the diabetic and control retina but the 
numbers of blood vessels expressing VEGF were 
significantly higher in diabetic retina than in the 
control retina, owing to the fact that microvascular 
complications in diabetic patients are caused by 
prolonged exposure to high glucose levels. Weak 
evidence of cytoplasmic immunoreactivity for 
VEGF was noted in the inner nuclear layer of the 
control retina (Figure 5d).
Intensive IL-1β staining was observed in the 
vascular endothelium as a direct consequence of 
chronic hyperglycemia and in the inner nuclear 
layer, where most of the cells expressed inflam-
matory cytokines. In addition, there were 
positive cells in the outer nuclear layer of the 
retina and in the ganglion cell layer cells and 
retinal pigment epithelium cells (Figure 6a). No 
Figure 3. Retinal capillary wall of a 62-year-old man affected 
by diabetes. Normal appearance of endothelial cells (en) and 
pericytes (pc). Internal basement membrane (ibm) is very thin 
and the external basement membrane (ebm) is significantly 
thickened with some electro-dense granules and vacuoles. 
Note that the border between basement membrane and Müller 
cells and adjacent Müller cells (star) is irregular. Magnification 
20,000×.
Figure 4. Retinal capillary wall of an 83-year-old woman 
affected by diabetes. External basement membrane is 
significantly thickened and root-like extensions formed deeply 
in between Müller cells. Magnification 20,000×.
Table 1. Thickening of the BM of retinal capillaries during aging.
Patients 6 years old 62 years old 81 years old 84 years old
Thickness of the BM 280 nm 450 nm 480 nm 500 nm
P value = 0.0004. The results were considered statistically significant when P <0.01.
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IL-1β immunoreactivity was detected in the 
negative control sample (Figure 6b).
Subsequently, we performed immunohisto-
chemistry for IL-6 and compared the expression 
level in the RPE layer between the diabetic and 
control retina. We found that IL-6 immunoreactiv-
ity was stronger in RPE cells from diabetic donor 
eyes (Figure 7a) compared with those from control 
eyes (Figure 7b).
Regarding immunostaining for TNF-α, faint 
immunostaining was barely detectable in the con-
trol retina, and was confined to a few glial cells and 
their processes and blood vessels (Figure 8d). 
However, the intensity of the immunostaining and 
the number of stained cells were noticeably greater 
in retina sections from diabetic eyes (Figure 8a–c). 
Based on the morphologic assessment, the immu-
nostaining for TNF-α in diabetic eyes was mostly 
associated with glial cells located in the nerve fiber 
and retinal ganglion cell layers (Figure 8b, c). For 
example, at the level of light microscopy, Müller 
cells are characterized by their radial orientation, 
and astrocytes are characterized by their darker, 
smaller, and irregular nucleus relative to that of 
ganglion cells, and by their close localization to the 
blood vessels of the inner retina (Figure 8c). 
Immunohistochemical examination of retinal sec-
tions from control eyes revealed a clearly detectable 
immunostaining for TNF-α that was limited to a 
few glial cells and their processes (Figure 8d). In 
diabetic eyes, the intensity of the immunostaining 
and the number of stained cells for TNF-α were 
notably greater than that in normal eyes. Positive 
immunostaining for TNF-α receptor-1 in retinal 
Figure 5. Immunohistochemical staining of human retina for vascular endothelial growth factor (VEGF). In diabetic retina (a, b) 
VEGF immunoreactivity was observed in retinal pigment epithelial cells, retinal microvascular endothelial cells, retinal pericytes, and 
Müller cells. As it is visible in (c) VEGF immunostaining has been found in vascularized areas (boxed area). VEGF immunoreactivity 
was weakly noted in the inner nuclear layer in the normal control retina (d) (magnification 40×).
Table 2. Thickening of the BM of retinal capillaries during 
diabetes.
Eyes (n) Media ± Standard deviation
Controls 21 292.4 nm ± 24.3
Diabetic patients 21 583.1 nm ± 38.52
P value 0.0001
The results were considered statistically significant when P <0.01.
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sections from diabetic eyes was detectable in the 
cytoplasm as well as on the cell surface (Figure 5b). 
In addition to the faint immunostaining observed in 
all retinal layers, which was probably associated 
with glial cell processes or blood vessels, immu-
nostaining for TNF-α was predominant in most 
large cell bodies in the retinal ganglion cell layer.
Using the supply of diabetic and non-diabetic 
ocular tissue that was at our disposal, we sought to 
examine the localization of ICAM-1 in the diabetic 
retina compared to the non-diabetic retina (Figure 
9). As shown in Figure 9a, diabetic retinas showed 
high levels of ICAM-1 expression, which was 
localized in the blood vessels of retina including 
the nerve fiber and outer-plexiform layers. Only 
faint immunoreactivity was seen in the retinas 
from control eyes (Figure 9b).
The expression of ICAM-1 is increased early in 
diabetic retinopathy and has been associated with 
increased TNF-α, leukostasis, and subsequent 
endothelial cell death, characteristic of the disease. 
These findings suggest that cytokines and the 
resulting neuroinflammation cause several of the 
hallmark features of diabetic retinopathy.
Our results demonstrate a novel interaction 
which may occur between the production of a pro-
inflammatory cytokine and VEGF involvement in 
diabetes. Immunohistochemical results for growth 
factors and pro-inflammatory cytokines are shown 
in Table 3; the results of immunopositivity were 
confirmed by statistical analysis (Figure 10). 
There were statistical differences between the his-
tological of diabetic retina and control retina in 
Figure 6. Immunohistochemical staining of human retina for interleukin-1beta (IL-1β). In diabetic retina (a) immunostaining for IL-
1β was observed in the inner nuclear layer and in the retinal pigment epithelium. No immunoreactivity for IL-1β was detected in the 
negative control sample (b) (magnification 40×).
Figure 7. Immunohistochemical staining of human retina for interleukin-6 (IL-6). Immunoreactivity for IL-6 was stronger in RPE 
cells from diabetic eyes (a). IL-6 immunoreactivity was not observed in the normal retina (b) (magnification 40×).
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terms of immunoreactivity for growth factors and 
pro-inflammatory cytokines.
Control sections in which the primary antibod-
ies were omitted or replaced with non-immune sera 
were all negative for specific immunostaining.
Discussion
BM thickening is one of the most widely studied 
morphological changes occurring in the microvas-
cular system during diabetes and aging. It is not 
clear which of the many factors really contribute to 
Figure 9. Immunohistochemical analysis of human retina for intracellular adhesion molecule-1 (ICAM-1). In diabetic retinas (a) 
immunoreactivity for ICAM-1 was localized in the inner layer and in blood vessels of the retina. Only faint immunoreactivity was 
seen in the retinas from control eyes (b). Magnification 40×.
Figure 8. Immunohistochemical analysis of human retina for TNF-α. In diabetic retinas immunoreactivity for TNF-α was observed 
in the glial cells (a), in the nerve fiber and retinal ganglion cell layers (b, c). In control eyes immunostaining for TNF-α was observed 
in few glial cells (d). Magnification 40×.
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the development of the vascular disease. A number 
of factors have been implied to contribute to an 
increase of BM thickening during aging and diabe-
tes. It has been proposed that increased polyol 
pathway activity within the microvascular cells32 
may lead to damaging accumulations of intracel-
lular polyalcohols in vascular cells and changes in 
the activities of enzymes involved in BM synthesis 
or breakdown.33 There is also evidence of reduced 
activity of the enzymes involved in BM catabo-
lism33 and increased activity of enzymes involved 
in BM synthesis. Susceptibility to proteolytic 
resorption of BM may also be altered in diabetic 
patients through non-enzymatic glycosylation and 
associated oxidative modification of the basal 
membrane proteins.34 The occurrence of capillary 
BM thickening in a wide variety of tissues suggests 
that this change in the capillary wall may be related 
to a deterioration of some tissue functions during 
senescence and disease. Capillary BM thickening, 
secondary to both diabetes and aging, is accompa-
nied by pathological changes in the cellular com-
ponents of the capillary wall. In diabetes, there is a 
selective loss of retinal capillary pericytes35 while, 
during senescence, both pericytes and endothelial 
cells are lost, so that certain areas of the retina 
become avascular. This may underline the age-
related loss of neural elements from the retina.36
Our study has revealed that in adult humans, 
with increased age, vacuoles accumulated in the 
BM of retinal capillaries on the glial interface, dem-
onstrating the existence of a statistically highly sig-
nificant correlation between the amount of 
vacuolization and patient age. The fact that the vac-
uolization occurred in all of the samples we tested 
and that it was increased with age, strongly sug-
gests that it was attributable to the normal aging 
process. Previous studies have shown that capillar-
ies in mature animals of several species (monkeys, 
dogs, cats, and rats) do not present vacuoles in the 
BM as seen in adult humans.37 It is therefore possi-
ble that the process of vacuolization concerning the 
BM might be a phenomenon specific in humans. It 
is not clear by what mechanism BM vacuoles are 
created and how the hypoxic stress might be a con-
tributing factor.38 It may be also possible that the 
vacuoles are remnants of degenerated pericytes. 
This would imply a turnover of degenerating and 
regenerating pericytes throughout the human lifes-
pan, which could also explain the multiple BM 
sheaths.39 We identified changes in the morphology 
of pericytes with a reduction in coverage of endothe-
lium in the early stages of retinal vascular aging. 
Close contact between pericytes and the endothe-
lium is thought to be necessary for vascular stabil-
ity.30 Our findings of reduced pericyte coverage and 
BM thickening may limit communication between 
endothelial cells and pericytes and thus contribute 
to the progressive age-related vessel instability. 
Pericytes also regulate endothelial cell prolifera-
tion. The vascular abnormalities such as spiraling 
and looping observed in the present study are sug-
gestive of reduced contacts between pericytes and 
endothelial cells, combined with an increased level 
of VEGF expression.31 The development of retinal 
vascular lesions is associated with the normal pro-
gression of aging, and this process has a striking 
similarity to the development of retinal vascular 
lesions observed in the pathogenesis of diabetic 
retinopathy. Interestingly, apoptosis was deter-
mined to be the underlying mechanism for the loss 
Table 3. Expression levels of VEGF, IL-1β, IL-6, TNF-α, and 
ICAM in DR and control specimens, and respective levels of 
statistical significance (t-test).
Diabetic retina
21 patients; 1 
specimen for each 
patient (%)
Control retina
21 patients; 1 
specimen for 
each patient (%)
P value
VEGF 75.00 ± 7.60 27.75 ± 6.27 <0.00001
IL-1β 62.5 ± 6.46 8.12 ± 2.90 <0.00001
IL-6 69.50 ± 4.75 6.00 ± 2.07 <0.00001
TNF-α 74.12 ± 4.32 20.75 ± 4.62 <0.00001
ICAM 59.75 ± 5.70 19.50 ± 5.55 <0.00001
The results were considered statistically significant when P <0.05.
Figure 10. Pro-inflammatory cytokines and VEGF positive 
cell index in the diabetic and control retina. The bar graph 
indicates the mean % positive cells to growth factors and pro-
inflammatory cytokines ± SD. Statistical analysis is performed 
using Student’s t-test. *P <0.05.
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of endothelial cells and pericytes. Our studies indi-
cate that the development of retinal vascular lesions 
shows histological and pathogenetic similarities 
both in the elderly and diabetics. Therefore, diabe-
tes is considered a metabolic disease that acceler-
ates the progression of aging through the 
development of vascular BM thickening in retinal 
and glomerular capillaries,40 secretion of specific 
glycoproteins,41 free radical formation resulting in 
oxidative stress, decline in cognitive function,42 and 
BM thickening in muscle.
It has recently been suggested that the combina-
tion of glycation and oxidation may be very impor-
tant in protein modification of the extracellular 
matrix occurring in diabetes and aging. Our work 
confirms pathological changes of the retinal capil-
lary wall during aging and diabetes. In diabetes, 
there is a selective loss of pericytes in the retinal 
capillary, while during senescence, both pericytes 
and endothelial cells are lost, leaving certain areas 
of the retina as avascular. This confirms age- and 
diabetes-related loss of neural elements in the ret-
ina. Hence compensatory changes occur in the cap-
illary walls, which have the potential to impair 
nutrient exchange and also to have a negative 
impact on neuronal function. A decrease in capil-
larity stability, culminating in vessel loss and local-
ized angiogenesis in response to hypoxia, produces 
reduced ability of the microvasculature to meet the 
metabolic needs of the parenchyma.
Müller cells, astrocytes, and microglia are the 
cells of the local innate immune system. Under 
stress, they become active and produce pro-
inflammatory cytokines and growth factors in 
order to reconstruct the tissue homeostasis, but in 
chronic pathologies such as diabetic retinopathy, 
the persistent inflammatory response leads to cel-
lular death or damage. Liou et al.43 have recently 
confirmed that the microglia are involved in acti-
vation even at the beginning of diabetic pathology, 
producing a wide range of pro-inflammatory 
cytokines, such as IL-1β, IL-3, IL-6, TNF-α, and 
other inflammation mediators like 51 ROS, gluta-
mate, VEGF, lymphotoxins, metalloproteinase, 
and NO. These mediators induce the expression of 
adhesion molecules (I-CAM and V-CAM) in vas-
cular cells for lymphocytes and monocyte-mac-
rophages, cellular apoptosis, leukocyte infiltration, 
and the weakening of the hemato–retinal barrier.43 
The Langmann’s group has detected that the 
microglial cells are the ones responsible for an 
increased retinal production of iNOS, IL-1β, MIP-
1α, IL-6, and M-CSF.44 Shelton et al.45 have 
observed an increase in IL-1β, IL-6, IL-8, IL-13, 
IP-10, ICAM-1, and NO in Müller and endothelial 
cells during the course of diabetes, confirming 
their participation in the inflammatory process. 
Owing to the fact that IL-1β is the main cytokine 
able to trigger the neuroinflammatory cascade, Liu 
et al.5 have also considered its role in the amplifi-
cation of the inflammation itself. This study has, in 
fact, highlighted that IL-1β secretion begins in the 
vascular endothelium as the direct consequence of 
chronic hyperglycemia, which stimulates the 
endothelial, macroglial, and microglial cells via 
the autocrine and the paracrine pathways, which do 
respond not only by activation signals, but also via 
the strengthening of IL-1β synthesis, thus exalting 
the inflammatory process.46
The cytokine TNF-α is synthesized by stimu-
lated monocytes and macrophages and functions in 
a cellular communication network. Additionally 
TNF-α stimulates the production of monocyte 
chemotactic protein by retinal pigment epithelial 
cells which makes the process self-stimulating. 
Cytokines such as IL-1β, TNF-α, and IL-6 have 
been shown to directly activate microglia. For 
example, TNF-α decreases cAMP levels within 
microglia, leading to a more destructive pheno-
type. Our results confirm the induction of pro-
inflammatory cytokines TNF-α and IL-1β within 
the retina as a result of diabetes. The most likely 
source of these cytokines is retinal microglia. 
However, other retinal cell types (e.g. pericytes) 
release pro-inflammatory cytokines in response to 
diabetic stress. Upon their release, these cytokines 
may propagate the inflammatory response within 
the retina, leading to an increased leukocyte infil-
tration. Activation of leukocytes leads to enhanced 
synthesis of cyclooxygenase and lipoxygenase 
which convert arachidonic acid into peroxide 
metabolites that further stimulate cytokine secre-
tion through a positive feedback mechanism. Given 
their functions, these signals represent potential 
targets for therapeutic procedures.
Besides inflammatory mediators mentioned 
above, it is well known that many other mediators 
are expressed inside the retinal tissue during the 
course of diabetes, since it is now clear that inflam-
mation plays an essential role in diabetic retinopa-
thy.47 It is generally thought that the microglial cells 
also indirectly intervene in their production, due to 
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their ability, via the production of mentioned mole-
cules, to behave as chemoattractants towards the 
other leukocytes, especially the neutrophils and 
lymphocytes, which can strengthen the inflamma-
tory process. Accumulating evidence suggests that 
leukocytes play an important role in the pathogene-
sis of diabetic retinopathy. Histopathologic studies 
have demonstrated many capillary occlusions 
caused by increased numbers of polymorphonuclear 
leukocytes in the retinas of diabetic patients and of 
leukocytes in the retinas of rats with chemically-
induced diabetes.48 Moreover, the activity of leuko-
cytes trapped in the diabetic retina was found to be 
elevated, which may increase vascular permeability 
through endothelial dysfunction and damage to the 
blood–retina barrier:48 these trapped leukocytes may 
produce more oxygen-derived free radicals than 
normal leukocytes. Retinal hypoxia and neovascu-
larization were reported to be associated with the 
presence of leukocytes in the diabetic retina.49
Additional clinical and experimental investiga-
tions appear to be necessary to better identify the 
causes and mechanisms of vascular changes during 
aging and diabetes, to determine whether treatment 
to prevent retinal capillary BM thickening is also 
effective in preserving the cellular elements of reti-
nal capillaries and the surrounding tissue. Further 
research should focus on the inflammatory mecha-
nisms of the development of diabetic retinopathy 
and should assess the possible effectiveness of 
anti-inflammatory therapy in the treatment and 
prevention of diabetic microangiopathy.
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